A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate
Clinical trial NCT02960438 · COMPLETED
Trial details
- NCT number
- NCT02960438
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2018-02-28
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.